Journal Policy

1. Open Access Policy
All articles published by KJAR are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers.

2. Licence and Copyright policy
KJAR applies the Creative Commons Attribution (Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)) license For non-commercial purposes, which lets others distribute and copy the article, and include in a collective work, as long as they credit the author(s) and provided they do not alter or modify the article.

This license lets authors hold the copyright without restrictions and let others remix, tweak, and build upon their work non-commercially, as long as the author and original source are properly cited.

3. Archiving
This journal utilizes the  LOCKSS (Lots of Copies Keep Stuff Safe) system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration. 

4. Confidentiality
Submitted manuscripts are considered confidential materials, and the journal will not disclose them to anyone other than individuals involved in the processing and preparing the manuscript for publication (if accepted). These individuals include editorial staff, corresponding authors, reviewers, and editors. However, if misconduct is suspected, the manuscript may be disclosed to members of the journal's ethics committees and institutions/organizations involved in resolving the misconduct. The journal will follow appropriate COPE flowcharts as needed.

5. Changes  to Authorship 
Authors should carefully consider the list and order of authors before submitting their manuscript and provide the final list of authors at the time of submission. Any changes to the authorship list, including the addition, deletion, or rearrangement of authors, should only be made before the manuscript has been accepted and should be approved by the journal editor. To request a change, the corresponding author must provide the reason for the change and obtain written confirmation (such as an email or letter) from all authors agreeing to the addition, removal, or rearrangement. If an author is being added or removed, their confirmation is also required.

6. Appeals and complaints
If any issues arise regarding authorship or the peer-review process, including those that arise after publication, they should be brought to the attention of the Editor-in-Chief. The Editor-in-Chief will investigate the claims by gathering information from all parties involved and suggest a course of action in accordance with academic ethical principles set forth by the Committee on Publishing Ethics (COPE; https://publicationethics.org/). The review or publication process may be halted until the issue is resolved.

7. Misconduct
Any actions that compromise the integrity of the publication process, violate journal policies, publication ethics, or any applicable guidelines/policies specified by COPE, WAME (World Association of Medical Editors), and ICMJE (International Committee of Medical Journal Editors) are considered misconduct. Suspected cases of misconduct will be investigated in accordance with COPE guidelines.

8. Fundamental errors in published works
If an author discovers a substantial error or inaccuracy in their published work, it is their responsibility to inform the journal editor as soon as possible and collaborate with the editor to either correct or retract the paper.

9. Conflicts of Interest/Competing Interests
All authors are required to disclose any conflicts of interest they may have with the publication of the manuscript or with any institution or product mentioned in the manuscript that may impact the study's outcome. Additionally, authors must disclose any conflicts of interest they may have with competing products mentioned in their manuscript.

The journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript.

10. Human Rights and Informed Consent
All manuscripts concerning clinical investigations with humans or human materials must include a statement that the project was approved by the local Ethical Committee and that all patients or test persons gave written consent before participation after adequate explanation.

11.Ethical Handling of Animals 
Experimental research on vertebrates or any regulated invertebrates must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. Field studies and other non-experimental research on animals must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. A statement detailing compliance with relevant guidelines and/or appropriate permissions or licences must be included in the manuscript. We recommend that authors comply with the IUCN Policy Statement on Research Involving Species at Risk of Extinction  and the Convention on the Trade in Endangered Species of Wild Fauna and Flora.

13.Plagiarism Policy
KJAR journal is a member of CrossRef and CrossRef services, e.g., CrossCheck. All manuscripts submitted will be checked for plagiarism CrossCheck/iThenticate. All manuscripts received towards KJAR journal are scanned for plagiarism before the review process using ithenticate similarity Check via Crossref.

KJAR journal tolerates only 10% of similarity, While more detected, authors, will be contacted to reduce the rate. In case, during the publication process or after the publication, plagiarism was detected, KJAR will take actions n accordance with academic ethical principles set forth by the Committee on Publishing Ethics (COPE). If more than 25% is detected, the manuscript will be rejected automatically.

14.Manuscript Withdrawal Policy

Authors may request the withdrawal of a manuscript by contacting the editorial office. However, such requests must be made before the manuscript enters the peer review process.

Withdrawal of manuscripts during the review process is strongly discouraged and may be considered unethical. Such actions waste the valuable time and resources of our reviewers and editors.

Authors who withdraw their manuscripts after the review process will be blacklisted. This means they will be prohibited from submitting any future manuscripts to this journal.

15. AI Writing Model Policy
With reference to the use of artificial intelligence (AI) technologies and AI language models in submitted research articles, this policy strives to provide transparency and assistance to authors.According to the COPE organization, authors are in charge of making sure that technologies are only used to enhance language and readability, and that the output is thoroughly checked and edited to prevent inaccurate, insufficient, or biased content. Additionally, authors must guarantee that their work is original and that an AI language model did not produce it.